- Live market news
- Stocks
- BBNX
Beta Bionics, Inc. Common Stock
BBNXStockUSA
Key figures
- Previous close
- 20.52
- Open
- 20.61
- Day range
- 19.28 – 20.73
- 52-week range
- —
- Volume
- 841K
Latest news on BBNXranked by Oyticker for market impact
- 55Impact
Class action lawsuit filed against Beta Bionics for alleged securities law violations
A class action lawsuit has been initiated against Beta Bionics (BBNX) alleging securities law violations. The suit targets shareholders and raises questions about disclosure adequacy or misrepresentation.
BBNXMedical DevicesHealthcare Technology - 72Impact
BBNX Securities Class Action Filed Amid iLet FDA Compliance Issues
Beta Bionics faces a securities fraud class action lawsuit covering shareholders who acquired stock during an unspecified period, coinciding with FDA compliance concerns around its iLet artificial pancreas system.
BBNXMedical DevicesHealthcare Technology - 45Impact
Securities class action filed against Beta Bionics; investor deadline November 3, 2026
Law firm Kaplan Fox has initiated a securities class action against Beta Bionics (BBNX) covering the period July 30, 2025 to February 24, 2026, with a November 3, 2026 deadline for investors to join.
BBNXHealthcare TechnologyMedical Devices - 72Impact
BBNX Securities Class Action Filed Amid iLet FDA Compliance Issues
Beta Bionics faces a securities fraud class action lawsuit tied to FDA compliance problems with its iLet artificial pancreas system, creating litigation risk and potential disclosure liability.
BBNXMedical DevicesHealthcare Technology
In detailthe same figures as in Oyticker Charts
Performance
Ranges & volume
- Open
- 20.61
- Prev. close
- 20.52
Risk · 1 year
Seasonality
What BBNX filed
- 27 Oct 2026
- 27 Oct 2026
- 16 Sept 2026
- 15 Sept 2026
Other event
- 29 Jul 2026
- 29 Jul 2026
- 22 May 2026
- 21 May 2026
Other event
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.